Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AstraZeneca PLC (AZN)

38.69   -0.06 (-0.15%) 04-23 16:00
Open: 38.63 Pre. Close: 38.75
High: 38.97 Low: 38.63
Volume: 4,780,624 Market Cap: 99208M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 39.045 - 39.267 39.267 - 39.508
Low: 37.999 - 38.248 38.248 - 38.519
Close: 38.222 - 38.653 38.653 - 39.122

Technical analysis

as of: 2019-04-23 4:22:56 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 48.37     One year: 50.57
Support: Support1: 38.35    Support2: 31.91
Resistance: Resistance1: 41.41    Resistance2: 43.30
Pivot: 39.97
Moving Average: MA(5): 38.86     MA(20): 40.49
MA(100): 39.33     MA(250): 38.33
MACD: MACD(12,26): -0.71     Signal(9): -0.45
Stochastic oscillator: %K(14,3): 11.98     %D(3): 8.59
RSI: RSI(14): 32.23
52-week: High: 43.30  Low: 34.38  Change(%): 10.2
Average Vol(K): 3-Month: 528892  10-Days: 481125

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AZN has closed above bottom band by 15.7%. Bollinger Bands are 9.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 06 Feb 2019 02:35:00 Z
AstraZeneca: Fasenra Gets FDA's ODD For Hypereosinophilic Syndrome - Quick Facts

Wed, 06 Feb 2019 02:35:00 Z
AstraZeneca: Fasenra Gets FDA's ODD For Hypereosinophilic Syndrome - Quick Facts

Tue, 05 Feb 2019 02:52:00 Z
AstraZeneca: RSV Medicine MEDI8897 Gets FDA's BTD, EMA's PRIME Eligibility

Tue, 05 Feb 2019 02:52:00 Z
AstraZeneca: RSV Medicine MEDI8897 Gets FDA's BTD, EMA's PRIME Eligibility

Fri, 25 Jan 2019 09:46:00 Z
AstraZeneca Announces Completion Of Divestment Of US Rights To Synagis

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2623.51
Shares Float (M) 2623.51
% Held by Insiders
% Held by Institutions 27.40
Shares Short (K) 16762
Shares Short P. Month (K)

Stock Financials

EPS 3.460
EPS Est. Current Year 1.910
EPS Est. Next Year 1.700
EPS Est. Next Quarter 0.450
Forward EPS 1.860
Book Value (p.s.) 8.560
PEG Ratio 1.09
Profit Margin 10.14
Operating Margin 7.92
Return on Assets (ttm) 3.6
Return on Equity (ttm) 16.2
Qtrly Rev. Growth 11.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -20.50
Operating Cash Flow (M) 2620.00
Levered Free Cash Flow (M) 3920.00

Stock Valuations

P/E 11.18
P/E Growth Ratio
P/BV 4.52
P/S 5634896384.00
P/CF 38.74

Dividends & Splits

Dividend 4.808
Dividend Yield 0.12
Dividend Pay Date 2019-03-27
Ex-Dividend Date 2019-02-28
Forward Dividend 1.400
Last Split Date 2015-07-27
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.